期刊文献+

Ki67、p53及EGFR在胃癌组织中的表达水平及临床意义 被引量:19

Expression of Ki67,p53 and EGFR in Gastric Cancer and Clinical Significance
下载PDF
导出
摘要 目的探讨Ki67、p53及EGFR在胃癌组织中的表达水平及其临床意义。方法收取行病理学检查的胃癌患者170例作为研究对象,对其胃癌组织及癌旁组织的石蜡切片进行ki67、p53及EGFR免疫组化染色。结果胃癌组织中Ki67、p53及EGFR阳性表达率分别为71.18%、55.88%及45.29%;癌旁组织中Ki67、p53及EGFR阳性表达率分别为31.76%、12.94%及10.59%。胃癌组织阳性表达率均明显高于癌旁组织,差异具有统计学意义(P<0.05)。3种指标均与肿瘤浸润深度、分化程度、淋巴结转移以及TNM分期密切相关,即随着肿瘤进展而其阳性率增高(P<0.05)。Ki67与p53、EGFR均呈正相关(P<0.05);p53与EGFR相关性不显著(P>0.05)。结论 Ki67、p53及EGFR与胃癌的发展关系密切,均可作为判断胃癌恶性程度及进展情况的可靠指标。 Objective To explore the expression of Ki67,p53 and EGFR in gastric cancer and clinical significance.Methods 170 patients with gastric cancer underwent pathological test in our department from May 2014 to May 2015 were se-lected to this study.The expression of Ki67,p53 and EGFR of tumor tissues and para-carcinoma tissues was detected by immuno-histochemical method.Results Expression rate of Ki67,p53 and EGFR in gastric cancer tissues was respectively 71.18%, 55.88%and 45.29%;in para-carcinoma tissues was respectively 31.76%,12.94% and 10.59%.Expression rate in gastric cancer tissues was obviously higher than para-carcinoma tissues with statistically significance (P〈0.05).Positive expression was related to the depth of invasion,degree of differentiation,lymphatic metastasis and TNM stages(P〈0.05).Ki67 expression was positively correlated with p53 and EGFR(P〈0.05),but correlation between p53 and EGFR had no statistically significance (P〉0.05).Conclusion Expression of Ki67,p53 and EGFR has close relation with gastric tumor ,which can be used as reliable inde-xes in judgement of tumor malignancy and development.
出处 《实用癌症杂志》 2017年第1期37-39,43,共4页 The Practical Journal of Cancer
关键词 KI67 P53 EGFR 胃癌 免疫组化 EGFR EGFR Gastric cancer Immunohistochemeical
  • 相关文献

参考文献7

二级参考文献54

  • 1Ming Gao,Xiu-Ju Liang,Zi-Sen Zhang,Wang Ma,Zhi-Wei Chang,Ming-Zhi Zhang.Relationship between expression of EGFR in gastric cancer tissue and clinicopathological features[J].Asian Pacific Journal of Tropical Medicine,2013,6(4):260-264. 被引量:21
  • 2龚志军,罗恩钊,陆琪,施达仁,朱慰祺.胃癌组织c-erbB_2蛋白表达的临床意义[J].中华肿瘤杂志,1996,18(4):299-301. 被引量:26
  • 3李冰,陈凛.IL-6、IL-6R及PCNA的表达与胃癌的临床关系研究[J].解放军医学杂志,2007,32(7):710-712. 被引量:8
  • 4Walerych D,Napoli M, Collavin L, et al. The rebel angel: mutant p53as the driving oncogene in breast cancer [J]. Carcinogenesis, 2012, 33(11):2007-2017.
  • 5Berger CE, Qian Y,Liu G, et al. p53, a target of estrogen receptor(ER) a, modulates DNA damage-induced growth suppression inER-positive breast cancer cells [J]. J Biol Chem, 2012, 287(7):30117-30127.
  • 6Sheri A, Dowsett M. Developments in Ki67 and other biomarkersfor treatment decision making in breast cancer [J]. Ann Ann Oncol,2012, 23(10): x219-x227.
  • 7Pathmanathan N, Balleine RL. Ki67 and proliferation in breast can-cer [J]. J Clin Pathol, 2013,66(6): 512-516.
  • 8Jin W,Chen BB, Li JY, et al. TIEG1 inhibits breast cancer invasionand metastasis by inhibition of epidermal growth factor receptor(EGFR) transcription and the EGFR signaling pathway [J]. MolCell Biol, 2012, 32: 50-63.
  • 9Tzaida 0,GogasH, Dafiii U, et al. Evaluation of the prognostic andp redictive value of HER-1 /EGFR in breast cancer patients partici-pating in a randomized study with dose-dense sequentialad juvantchemotherapy [J]. Oncology, 2007, 72(5-6): 388-396.
  • 10Niitsu N, Nakamine H, Okamoto M. Expression of nm23-Hl is as-sociated with poor prognosis in peripheral T-cell lymphoma, not oth-erwise specified [J]. Clin Cancer Res, 2011,17(5): 2893-2899.

共引文献35

同被引文献192

引证文献19

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部